Leach Technology Group Renews Supply Agreement with Biosite Incorporated, San Diego.Business Editors/High-Tech & Medical Writers WESTPORT, Conn.--(BUSINESS WIRE)--Feb. 10, 2003 The Leach Technology Group, Westport CT, a premier provider of contract services for design, development and manufacturing for the medical device industry, today announced the renewal of the Triage triage Division of patients for priority of care, usually into three categories: those who will not survive even with treatment; those who will survive without treatment; and those whose survival depends on treatment. (R) MeterPlus supply agreement with Biosite(R) Incorporated (Nasdaq:BSTE), San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. . LRE LRE Long-Reach Ethernet LRE Least Restrictive Environment LRE Law-Related Education LRE Long Range Ethernet (Cisco) LRE Launch and Recovery Element LRE Latest Revised Estimate LRE Lead Responsible Engineer LRE Low Bit-Rate Encoding Technology Partner GmbH, Munich and Noerdlingen, a subsidiary of Leach Technology Group, has worked for eight years with Biosite, in developing and manufacturing this instrument. A long-term supply agreement for Biosite's Triage MeterPlus was recently signed. Biosite's Triage MeterPlus is compact, intricate and simple to use. Used in conjunction with the Triage Panel testing device, the Triage MeterPlus provides a rapid, qualitative test platform for simultaneous and highly sensitive Adj. 1. highly sensitive - readily affected by various agents; "a highly sensitive explosive is easily exploded by a shock"; "a sensitive colloid is readily coagulated" detection of multiple analytes in hospital laboratories and emergency departments. With complex biological, chemical and micro-fluidic engineering elements supporting its precision and reliability, the Triage Panel is a proven and efficient diagnostic device with potential applications for a host of critical disease states. Robert F. Doman, President, Leach Technology Group, says: "We are very pleased to announce the renewal of this agreement. Collaborations such as this reinforce our dedication to Leach Technology Group's strategic mission of establishing successful long-term collaborations with our customers. We look forward to many years of working closely with Biosite, one of the leading biotechnology corporations in the U.S." The Leach Technology Group is a worldwide leader in outsourced medical device design, development, manufacturing and repair services. Members of this group are: Hauser Inc., Westlake Village, CA; UMM Electronics Inc., Indianapolis, IN; LRE Technology Partner GmbH, Munich, and Nordlingen, Germany. Hauser Inc. is a world-renowned, award-winning industrial design firm, offering design, user interface, human factors/ergonomics and rapid prototyping Building a part one layer at a time using a method of additive fabrication such as 3D printing. Such parts are used for concept modeling to determine if the product design meets the customer's expectations. services to many medical industry and commercial customers. UMM Electronics Inc. and LRE Technology Partner GmbH provide development, manufacturing and depot repair services for a broad range of medical electronics and analytical instruments for OEM (Original Equipment Manufacturer) The rebranding of equipment and selling it. The term initially referred to the company that made the products (the "original" manufacturer), but eventually became widely used to refer to the organization that buys the products and clients on a global basis. About Biosite A leader in the drive to advance diagnosis, Biosite Incorporated is a research-based company dedicated to the discovery and development of novel protein-based diagnostic tests that improve a physician's ability to diagnose debilitating de·bil·i·tat·ing adj. Causing a loss of strength or energy. Debilitating Weakening, or reducing the strength of. Mentioned in: Stress Reduction and life-threatening diseases. Biosite combines integrated discovery and diagnostics businesses to access proteomics research, identify proteins with high diagnostic utility, develop and commercialize products and educate the medical community on new diagnostic approaches that improve health care outcomes. Biosite's Triage(R) brand rapid diagnostic tests are used in approximately 50 percent of U.S. hospitals and in approximately 40 international markets. Information on Biosite can be found at www.biosite.com. Except for the historical information presented herein, matters discussed in this press release are forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including but not limited to statements that are preceded by, followed by, or that include the words "will"; "believes"; "should"; "intends"; "anticipates"; "plans"; "expects"; "estimates"; or similar statements are forward-looking statements. Risks and uncertainties include risks associated with sales, profitability, product discovery and development. Other risks that should be considered include, risks associated with expansion or development of a direct sales effort in domestic and international markets, and risks and expenses associated with litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , contract disputes, patent conflicts, product recalls, manufacturing delays and inefficiencies, shipment problems, seasonal customer demand, the timing of significant orders, changes in reimbursement policies, competitive pressures on average selling prices, changes in the mix of products sold, and the other risks detailed in Biosite's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. and other SEC filings. Biosite disclaims, however, any intent or obligation to update these forward-looking statements. Copies of Biosite's public disclosure filings are available from its investor relations Investor relations The process by which the corporation communicates with its investors. department. Biosite(R) and Triage(R) are registered trademarks of Biosite Incorporated, 11030 Roselle Roselle (rōzĕl`), borough (1990 pop. 20,314), Union co., NE N.J.; set off from Linden 1890 and inc. 1894. Chiefly residential, the borough has some industry. Street, San Diego, CA 92121. Tel: 858.455.4808 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion